Filing Details

Accession Number:
0001179110-18-008295
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-06-08 16:08:25
Reporting Period:
2018-06-06
Accepted Time:
2018-06-08 16:08:25
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
855654 Immunogen Inc IMGN Pharmaceutical Preparations (2834) 042726691
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1486519 Brannon David Johnston 830 Winter Street
Waltham MA 02451
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-06-06 10,000 $3.05 190,690 No 4 M Direct
Common Stock Disposition 2018-06-06 10,000 $11.02 180,690 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock option (right to buy) Disposition 2018-06-06 10,000 $3.05 10,000 $3.05
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
90,000 2017-07-18 2026-07-18 No 4 M Direct
Footnotes
  1. The transaction reported in this Form 4 was made pursuant to a 10(b)5-1 trading plan executed by the reporting person on March 7, 2018.
  2. Weighted average price of shares sold
  3. Exercisable in three equal installments over three years starting on the first year anniversary of the grant.